A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

Clinical trial NCT00987935 · COMPLETED

Trial details

NCT number: NCT00987935
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2009-10-01
Primary completion: 2014-07-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.